Abstract
We previously reported the expression of PRDM10 in skeletal cartilage during mouse embryonic development. In this study, we examined PRDM10 expression in blood, synovial fluid and synovium from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). PRDM10 mRNA was detected in all peripheral blood and RA synovial fluid, as well as in normal blood. We also performed immunohistochemistry with human synovium tissues. Compared to other PR/SET proteins including PRDM14, PRDM12, and SUV39H1, PRDM10 expression was conspicuous in cells of the synovial lining layer, subintimal layer, and perivascular layer in RA and OA synovium. Immunostaining using cultured fibroblast like synoviocytes detected PRDM10 mainly in the nucleus, with a small amount detected in the cytoplasm. Transforming growth factor-beta (TGF-β) treatment decreased PRDM10 expression in OA-derived FLS cells, whereas polyinosinic:polycytidylic acid or lipopolysaccharide treatment did not produce a distinct change of PRDM10 expression, PRDM10 expression was reversed by the smad inhibitor SB431542. Given that PRDM10 is highly expressed in human synovial tissues and is transcriptionally regulated by TGF-β, we suggest that PRDM10 might be involved in the pathogenesis of arthritis.
Similar content being viewed by others
References
Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, Sibilia J (2010) Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 12:R135
Brayer KJ, Segal DJ (2008) Keep your fingers off my DNA: protein–protein interactions mediated by C2H2 zinc finger domains. Cell Biochem Biophys 50:111–131
Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV, Dai Y (2010) Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci 6:599–612
Chang DH, Angelin-Duclos C, Calame K (2000) BLIMP-1: trigger for differentiation of myeloid lineage. Nat Immunol 1:169–176
Cheon H, YU SJ, Yoo D, Chae I, Song G, Sohn J (2002) Increased expression of pro‐inflammatory cytokines and metalloproteinase‐1 by TGF‐β1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 127:547–552
Chia NY, Chan YS, Feng B, Lu X, Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau MS (2010) A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468:316–320
Fog CK, Galli GG, Lund AH (2012) PRDM proteins: important players in differentiation and disease. BioEssays 34:50–60
Geiler J, Buch M, McDermott MF (2011) Anti-TNF treatment in rheumatoid arthritis. Curr Pharm Des 17:3141–3154
Huang S (2002) Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2:469–476
Karpus ON, Heutinck KM, Wijnker PJM, Tak PP, Hamann J (2012) Triggering of the dsRNA Sensors TLR3, MDA5, and RIG-I Induces CD55 Expression in Synovial Fibroblasts. PLoS ONE 7:e35606
Kim KC, Huang S (2003) Histone methyltransferases in tumor suppression. Cancer Biol Ther 2:491–499
Kumarasinghe DD, Hopwood B, Kuliwaba JS, Atkins GJ, Fazzalari NL (2011) An update on primary hip osteoarthritis including altered Wnt and TGF-beta associated gene expression from the bony component of the disease. Rheumatology (Oxford) 50:2166–2175
Lee B, Kim TH, Jun JB, Yoo DH, Woo JH, Choi SJ, Lee YH, Song GG, Sohn J, Park-Min KH, Ivashkiv LB, Ji JD (2010) Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. J Immunol 185:5926–5934
Liu H, Zhang R, Chen D, Oyajobi BO, Zhao M (2012) Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation. J Cell Physiol 227:952–963
Meda F, Folci M, Baccarelli A, Selmi C (2011) The epigenetics of autoimmunity. Cell Mol Immunol 8:226–236
Merrill JC, You J, Constable C, Leeman SE, Amar S (2011) Whole-body deletion of LPS-induced TNF-alpha factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis. Proc Natl Acad Sci USA 108:21247–21252
Park JA, Kim KC (2010) Expression patterns of PRDM10 during mouse embryonic development. BMB Rep 43:29–33
Peters AH, O’Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T (2001) Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323–337
Singh J, Arayssi T, Duray P, Schumacher H (2004) Immunohistochemistry of normal human knee synovium: a quantitative study. Ann Rheum Dis 63:785–790
Tragulpiankit P, Chulavatnatol S, Rerkpattanapipat T, Janwityanujit S, Somjarit S, Sirikhedgon U (2012) Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients. Int J Rheum Dis 15:315–321
Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC (2011) Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis 70:1482–1488
Wan B, Nie H, Liu A, Feng G, He D, Xu R, Zhang Q, Dong C, Zhang JZ (2006) Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 177:8844–8850
Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F, Perkins AS (2011) PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood 118:3853–3861
Acknowledgments
This work was supported by Grants from the National Research Foundation of Korea (NRF 2011-0006047). JA Park was beneficiary of the graduate student scholarship (S2-2009-000-00756-1), KOSEF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, JA., Kim, TH., Lee, B. et al. Expression of PRDM10 in arthritic synovial derived tissues. Genes Genom 35, 685–691 (2013). https://doi.org/10.1007/s13258-013-0119-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-013-0119-z